Feline hyperthyroidism is highly treatable with multiple options, and choosing the most appropriate management approach for each cat requires balancing effectiveness, welfare during treatment, and long-term quality of life.
Feline hyperthyroidism welfare involves choosing between management approaches that each have distinct welfare implications. Radioiodine treatment offers the highest cure rate and once completed requires no further treatment, representing the best long-term welfare outcome for cats that can tolerate the brief isolation required after treatment. Daily methimazole medication maintains cats in a managed state but requires owner adherence and cats who tolerate tablet administration or topical gel application. The welfare issue of concurrent kidney disease unmasking after treatment requires careful monitoring, as the hyperthyroid state artificially elevated kidney blood flow, and successful treatment may reveal pre-existing renal disease that was previously masked. The most welfare-positive management plan is individualized based on the cat's age, health status, and owner circumstances.